作者
Romain Le Pennec, Wolfgang Schaefer, Tulchinsky Mark, François LAMOUREUX, Paul Roach, Christoph Rischpler, Katherine Zukotynski, Christopher Christopher O'Brien, Declan Murphy, Pierre PASCAL, Gregoire Le Gal, Pierre-Yves Salaün, Pierre-Yves Le Roux
发表日期
2024/6/1
来源
Journal of Nuclear Medicine
卷号
65
期号
supplement 2
页码范围
241416-241416
出版商
Society of Nuclear Medicine
简介
241416
Introduction:
Although lung ventilation/perfusion scintigraphy is a widely used imaging test, different options are possible for the performance and interpretation of the scan. Various radiopharmaceuticals can be used for ventilation, including radioactive inert gases (81mKrypton or 133Xenon) or 99mTechnetium-labeled aerosols (carbon nanoparticles or DTPA). These tracers have different physical and physiological properties and are not approved in all countries. Different protocols are also possible for image acquisition, including planar, SPECT or SPECT/CT. Furthermore, the reporting criteria used for interpretation of both planar and SPECT scans are variable and data are lacking regarding which criteria are commonly used in daily practice.
The aim of this study was to assess current practices regarding the use and interpretation of lung scintigraphy in various clinical indications.
Methods:
An online survey …